Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus “at progression” cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

BACKGROUND: The role and timing of whole or stereotaxic brain radiotherapy (BR) in patients with advanced non-small cell lung cancer (aNSCLC) and asymptomatic brain metastases (aBMs) are not well established. This study investigates whether deferring BR until cerebral progression was superior to upf...

Descripción completa

Detalles Bibliográficos
Autores principales: Monnet, Isabelle, Vergnenègre, Alain, Robinet, Gilles, Berard, Henri, Lamy, Regine, Falchero, Lionel, Vieillot, Sabine, Schott, Roland, Ricordel, Charles, Chouabe, Stephane, Thomas, Pascal, Gervais, Radj, Madroszyk, Anne, Abdiche, Samir, Chiappa, Anne Marie, Greillier, Laurent, Decroisette, Chantal, Auliac, Jean Bernard., Chouaïd, Christos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053829/
https://www.ncbi.nlm.nih.gov/pubmed/33948123
http://dx.doi.org/10.1177/17588359211006983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053829/
https://www.ncbi.nlm.nih.gov/pubmed/33948123
http://dx.doi.org/10.1177/17588359211006983

Ejemplares similares